These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21040668)

  • 41. Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.
    Cook RC; Connors JM; Gascoyne RD; Fradet G; Levy RD
    Lancet; 1999 Nov; 354(9191):1698-9. PubMed ID: 10568575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary cutaneous intravascular large B-cell lymphoma treated with combination chemotherapy and complicated by rituximab-induced interstitial lung disease.
    Park GH; Kim CH; Chung WK; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Acta Derm Venereol; 2010 May; 90(3):296-8. PubMed ID: 20526551
    [No Abstract]   [Full Text] [Related]  

  • 43. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
    Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V
    Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment.
    Pescovitz MD; Book BK; Sidner RA
    N Engl J Med; 2006 May; 354(18):1961-3. PubMed ID: 16672715
    [No Abstract]   [Full Text] [Related]  

  • 45. Transformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumab.
    Linden MA; Bachanova V; Sachs Z; Young JA; Singleton TP; Ustun C
    Leuk Lymphoma; 2013 Jan; 54(1):174-6. PubMed ID: 22568510
    [No Abstract]   [Full Text] [Related]  

  • 46. Sodium valproate in combination with ganciclovir induces lysis of EBV-infected lymphoma cells without impairing EBV-specific T-cell immunity.
    Jones K; Nourse J; Corbett G; Gandhi MK
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e169-74. PubMed ID: 19196381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lymphoma with bladder involvement and renal transplantation].
    Chebil M; Martin X; Friaa S; Ezzeddine W; Garnier JL; Desmettre O; Maréchal JM; Gelet A; Dubernard JM
    Prog Urol; 1995 Feb; 5(1):102-5. PubMed ID: 7719353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy.
    Castagnola E; Dallorso S; Faraci M; Morreale G; Di Martino D; Cristina E; Scarso L; Lanino E
    J Hematother Stem Cell Res; 2003 Feb; 12(1):9-10. PubMed ID: 12662431
    [No Abstract]   [Full Text] [Related]  

  • 49. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma.
    Mentzer SJ; Fingeroth J; Reilly JJ; Perrine SP; Faller DV
    Blood Cells Mol Dis; 1998 Jun; 24(2):114-23. PubMed ID: 9628848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?
    Cheah CY; Seymour JF
    Leuk Lymphoma; 2014 Mar; 55(3):471-3. PubMed ID: 23906017
    [No Abstract]   [Full Text] [Related]  

  • 51. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
    Barkholt L; Linde A; Falk KI
    Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Posttransplant lymphoproliferative disorder.
    Everly MJ; Bloom RD; Tsai DE; Trofe J
    Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
    Smeltzer JP; Viswanatha DS; Habermann TM; Patnaik MM
    Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hodgkin-like lymphoma, simulating anaplastic large cell lymphoma in the patient after renal transplantation--unusual case report and literature review.
    Ziarkiewicz-Wróblewska B; Górnicka B; Gierej B; Suleiman W; Nowacka-Cieciura E; Durlik M; Bogdańska M; Wasiutyński A; Pileri SA
    Pol J Pathol; 2008; 59(1):63-9. PubMed ID: 18655373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
    Roychowdhury S; Peng R; Baiocchi RA; Bhatt D; Vourganti S; Grecula J; Gupta N; Eisenbeis CF; Nuovo GJ; Yang W; Schmalbrock P; Ferketich A; Moeschberger M; Porcu P; Barth RF; Caligiuri MA
    Cancer Res; 2003 Mar; 63(5):965-71. PubMed ID: 12615710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Measurement of rituximab concentration in the cerebrospinal fluid in CNS lymphoma].
    Kikuchi A; Kawada H; Iwaki Y; Machida S; Tsuchiya T; Fukuda R; Hotta T
    Rinsho Ketsueki; 2004 Dec; 45(12):1255-7. PubMed ID: 15678918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders.
    Boratyńska M; Smolska D
    Transpl Int; 2008 Jun; 21(6):605-8. PubMed ID: 18282244
    [No Abstract]   [Full Text] [Related]  

  • 59. Post-transplant lymphoproliferative disorder with Hodgkin's lymphoma and large B-cell lymphoma differentiation.
    Novoa-Takara L; Dincer A; Kampalath B; Van Tuinen P; Hariharan S; Chang C
    Histopathology; 2005 Sep; 47(3):333-4. PubMed ID: 16115242
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.